A new study combining antibodies and T-cells helped some HIV-positive people stay virally suppressed for months without daily ...
CAR-T stands for Chimeric Antigen Receptor T-cell therapy. Doctors harvest the patient’s T cells, the soldiers of the immune ...
Researchers led by a team from Mass General Brigham and the Ragon Institute have discovered why some people living with HIV who are given a treatment called broadly neutralizing anti-HIV antibodies ...
UCSF researchers have made strides toward an HIV cure, showing experimental immunotherapy can help control the virus without ...
African scientists have developed a nanoscale drug delivery system to treat pericarditis, a drug-resistant and lethal ...
Cell therapies, which have made waves in the treatment of blood cancer, are showing potential for solid tumors.
About 40 million people worldwide are living with HIV infection. In the United Kingdom, there are approximately 100,000 ...
Dr Hope Rugo explores how new data suggest immunotherapy could reshape the standard of care for early-stage HR+ and ...
A compounded form of imiquimod, a topical immune response modifier, showed promise as a treatment for ocular surface ...
Two studies suggest that T cells with stem-cell-like properties could work with antibody therapies to control HIV after a ...
A new study from UC San Francisco shows it may be possible to control HIV without long-term antiviral treatment—an advance ...
Antiretroviral drugs that prevent HIV and keep it in check have been transformative, but a cure has been a long sought goal.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback